Heart Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Heart Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

It is time to stop ignoring malignancy in heart transplantation: a call to arms.

Hauptman PJ, Mehra MR

St. Louis University Health Sciences Center, MO 63110, USA. hauptmpj@slu.edu

Increasing numbers of patients are surviving more than 5 years after heart transplantation. Despite the dramatic nature of coronary allograft vasculopathy, Cardiac Transplant Research Database data have shown, and International Society for Heart and Lung Transplantation Registry data suggest, that malignancy is the leading cause of death among long-term survivors of heart transplantation. Recommendations on malignancy screening are provided as well as an outline of areas of ongoing uncertainty.

Published 16 August 2005 in J Heart Lung Transplant, 24(8): 1111-3.
Full-text of this article is available online (may require subscription).

© 2005-2008 Heart Transplant Research Today. All Rights Reserved.